The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 28th 2024
Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.
Providing Patient Care at All Levels
August 9th 2019Lindsay Davis, PharmD, BCPS, ASH-CHC, TTS and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, both professors at t Midwestern University College of Pharmacy – Glendale, Glendale, AZ, discuss pharmacists as patient care providers, and managing patients taking anticoagulation medications.
Watch
Scott Gottlieb to Serve as Keynote Speaker for the 37th Annual Chemotherapy Foundation Symposium
August 9th 2019Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), named public health expert and former commissioner of the Food and Drug Administration (FDA) Scott Gottlieb, M.D., as the keynote speaker for the 37th Annual Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow.®
Read More
Discover Pharmacy Camp Has High School Students Exploring the Profession
August 8th 2019High school students will explore pharmacy careers through activities such as extracting DNA from strawberries, and getting out of a pharmacy-themed escape room, during the upcoming Discover Pharmacy day camp, at Wilkes University.
Read More
Pharmacy, Public Health Associations Call for Action Against Gun Violence
August 8th 2019Pharmacy and public health associations have released statements following the recent shootings in California, Texas, and Ohio, and some are discussing what actions they can take to prevent further gun-related injury and death.
Read More
Interventions Demonstrate Success for Increasing Viral Load Suppression in HIV
August 7th 2019A study in the Bukoba municipality of Tanzania has suggested that scaling up HIV testing, improving linkages to HIV care, and strengthening retention of antiretroviral therapy interventions can help increase viral load suppression (VLS).
Read More
FDA Assessing Data Manipulation Concerns with Gene Therapy Product
August 7th 2019Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old.
Read More
Analysis Suggests Stimulant Treatment Prevents Some Outcomes of ADHD
August 6th 2019An analysis of previous studies of children and young adults with ADHD has quantified the extent to which stimulant treatment reduces the development of mood disorders, problems in school, conduct disorders, substance use disorders, and other problems.
Read More
The Business of Using Generic Brand OTC Products
August 6th 2019Katie Westgerdes, PharmD, pharmacist at the ONU Healthwise Pharmacy, discusses the Cardinal Health generic brand products, LEADER, and their place in the ONU Healthwise Pharmacy during the 2019 Cardinal Health Retail Business Conference.
Watch
The Challenges in Prescription Drug Abuse Prevention Programs
August 5th 2019Larry Schieber, RPh, pharmacist and owner of Shieber Pharmacy in Circleville, OH discusses the challenges in prescription drug abuse prevention programs at the 2019 Cardinal Health Retail Business Conference in Nashville, TN.
Watch
The Importance of Collaboration Between Pharmacy Students and Other Medical Professionals
August 4th 2019Kaelen C. Dunican, PharmD, Professor at Massachusetts College of Pharmacy & Health Sciences, MA, discusses different opportunities for collaboration between pharmacy students and other medical professionals, and how those collaborations can improve students' learning.
Watch
New Congress Offers Expert Evaluation of Latest Neurology Trends
August 3rd 2019The 1st annual International Congress on the Future of Neurology will be held on September 27-28, 2019 in New York City, featuring a rigourous agenda of presentations, question and answer sessions, and lightning rounds highlighting topics across the breadth of neurology.
Read More
FDA Approves First Therapy for Adults with Rare TGCT
August 2nd 2019Officials with the FDA have granted approval to pexidartinib (Turalio, Daiichi Sankyo) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.
Read More